The Smart Inhalers market was valued at USD XX billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 21.26% from 2024 to 2030, reaching USD XX billion by 2030. This rapid market expansion is driven by the rising prevalence of respiratory diseases like asthma and COPD, along with technological advancements, increased smartphone adoption, and growing awareness of smart health solutions. These factors are expected to significantly boost the demand for smart inhalers between 2024 and 2030.
DelveInsight’s Smart Inhalers Market Insights report provides the current and forecast market analysis, individual leading Smart Inhalers companies’ market shares, challenges, Smart Inhalers market drivers, barriers, and trends, and key Smart Inhalers companies in the market.
Key Takeaways from the Smart Inhalers Market Report
As per DelveInsight estimates, North America is anticipated to dominate the global Smart Inhalers market during the forecast period.
Notable Smart Inhalers companies such as Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline plc, AptarGroup, Inc, Novartis AG, OPKO Health, Inc, BreatheSuite Inc, adherium, Propeller Health, H&T Presspart Manufacturing Ltd, Zeolr Technologies Pvt Ltd , Findair Sp. z o. o, Lupin, Personal Air Quality Systems Pvt Ltd (PAQS), Biocorp, Cognita Labs, and several others are currently operating in the Smart Inhalers market.
In April 2025, the U.S. Food and Drug Administration (FDA) approved Teva’s digital inhaler, which combines built-in sensors with a companion mobile app to assist in managing asthma and COPD symptoms.
To read more about the latest highlights related to the Smart Inhalers market, get a snapshot of the key highlights entailed in the Global Smart Inhalers Market Report
Smart Inhalers Overview
Smart inhalers are advanced medical devices designed to improve the management of respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These inhalers are equipped with sensors, connectivity features, and digital platforms that provide real-time monitoring of medication usage and symptom tracking, enhancing patient adherence to treatment regimens and allowing for more personalized care.
Smart Inhalers Market Insights
North America is expected to lead the Smart Inhalers market in 2023 and maintain this position throughout the forecast period from 2024 to 2030. This dominance is driven by the rising prevalence of chronic respiratory diseases and the growing need for enhanced management solutions. Technological advancements in smart inhalers, regulatory support, and the introduction of innovative devices by key market players are projected to significantly boost market growth during this period.
According to the Centers for Disease Control and Prevention (CDC) data from 2023, around 11.5% of U.S. adults aged 18 and older were current cigarette smokers in 2021, which translates to approximately 28.3 million individuals. Additionally, over 16 million Americans suffer from smoking-related diseases. Smoking is a major risk factor for the development of Chronic Obstructive Pulmonary Disease (COPD) in the population.
To know more about why North America is leading the market growth in the Smart Inhalers market, get a snapshot of the Smart Inhalers Market Outlook
Smart Inhalers Market Dynamics
According to the World Health Organization (WHO) data, asthma affected 262 million people in 2019, and by 2023, 392 million people were living with Chronic Obstructive Pulmonary Disease (COPD), with the majority residing in low and middle-income countries. Smart inhalers are designed to improve the management of these respiratory conditions by integrating advanced technology. Equipped with sensors and connectivity features, smart inhalers allow for real-time monitoring of medication use and symptom tracking. They also provide reminders for medication adherence and detailed analytics to enable more personalized treatment plans.
Global urbanization has led to an increase in respiratory illnesses due to higher pollution levels and lifestyle factors like smoking, which also contributes to second-hand smoke exposure. The WHO reported in 2022 that in 2019, 99% of the global population lived in areas with air quality below the organization’s standards. Smart inhalers play a key role in managing respiratory conditions by offering real-time monitoring and personalized feedback, which helps improve treatment adherence. They are also integrated with digital health platforms to address challenges posed by poor air quality and unhealthy lifestyle choices, optimizing the management of respiratory health.
Smart Inhalers Market Drivers:
Rising prevalence of respiratory conditions such as asthma & COPD
Coupled with advancements in technology
Growing smartphone adoption
Increasing awareness of smart health solutions
Get a sneak peek at the Smart Inhalers market dynamics @ https://www.delveinsight.com/report-store/smart-inhalers-market
Coverage: Global
Study Period: 2022 to 2032
Key Smart Inhalers Companies: eva Pharmaceutical, AstraZeneca, GlaxoSmithKline plc, AptarGroup, Inc, Novartis AG, OPKO Health, Inc, BreatheSuite Inc, adherium, Propeller Health, H&T Presspart Manufacturing Ltd, Zeolr Technologies Pvt Ltd , Findair Sp. z o. o, Lupin, Personal Air Quality Systems Pvt Ltd (PAQS), Biocorp, Cognita Labs, and others.
Which MedTech key players in the Smart Inhalers market are set to emerge as the trendsetter, explore @ Smart Inhalers Companies
Table of Contents
1. Smart Inhalers Market Report Introduction
2. Smart Inhalers Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Smart Inhalers Market Key Factors Analysis
6. Smart Inhalers Market Porter’s Five Forces Analysis
7. Smart Inhalers Market Layout
8. Smart Inhalers Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/
